Literature DB >> 2991133

Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis.

A Marcadet, C Massart, G Semana, R Fauchet, O Sabouraud, M Merienne, J Dausset, D Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2991133     DOI： 10.1007/bf00430598

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  12 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 2.  DNA polymorphism of HLA class I and class II regions.

Authors:  D Cohen; P Paul; I Le Gall; A Marcadet; M P Font; O Cohen-Haguenauer; B Sayagh; H Cann; J M Lalouel; J Dausset
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

3.  HLA-DW2, viral immunity and family studies in multiple sclerosis.

Authors:  G J Stewart; A Basten; J Guinan; H V Bashir; J Cameron; J G McLeod
Journal:  J Neurol Sci       Date:  1977-06       Impact factor: 3.181

4.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Clusters of HLA class II beta restriction fragments describe allelic series.

Authors:  D Cohen; I Le Gall; A Marcadet; M P Font; J M Lalouel; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 6.  HLA and disease 1982--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

7.  Multiple Ia-like molecules characterize HLA-DR2-associated haplotypes which differ in HLA-D.

Authors:  G T Nepom; B S Nepom; M E Wilson; E Mickelson; P Antonelli; J A Hansen
Journal:  Hum Immunol       Date:  1984-07       Impact factor: 2.850

8.  Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex.

Authors:  D Cohen; P Paul; M P Font; O Cohen; B Sayagh; A Marcadet; M Busson; G Mahouy; H M Cann; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.

Authors:  D Cohen; O Cohen; A Marcadet; C Massart; M Lathrop; I Deschamps; J Hors; E Schuller; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962
View more
  10 in total

1.  Association between the lack of HLA-DQw6 and the low incidence of multiple sclerosis in Hungarian Gypsies.

Authors:  K Takács; B Kálmán; E Gyódi; T Tauszik; G Pálffy; L Kuntár; A Guseo; C Nagy; G Petrányi
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy.

Authors:  A Marcadet; L Gebuhrer; H Betuel; J Seignalet; A C Freidel; C Confavreux; M Billiard; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 3.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

4.  HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.

Authors:  N Cohen; C Brautbar; M P Font; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 5.  Genetic factors in sleep disorders.

Authors:  J D Parkes; C B Lock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

6.  HLA antigens in multiple sclerosis of northern Spanish population.

Authors:  C López-Larrea; D F Uría; E Coto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

7.  An immunogenetic heterogeneity in multiple sclerosis.

Authors:  J Hillert; M Grönning; H Nyland; H Link; O Olerup
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 8.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

9.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15

Review 10.  Molecular basis of human leukocyte antigen class II disease associations.

Authors:  D Charron
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.